Grace Therapeutics (GRCE) Income towards Parent Company (2011 - 2026)
Grace Therapeutics' Income towards Parent Company was -$2.13 million in fiscal Q2 2027 (quarter ended Sep 30, 2026), compared with -$938,000 a year earlier.
Grace Therapeutics (GRCE) Income towards Parent Company (2011 - 2026) Analysis & Trends
On a trailing twelve-month basis, Grace Therapeutics' Income towards Parent Company was -$21.41 million through Sep 30, 2026; for FY2026 (ended Mar 31, 2026), it was -$7.79 million.
- In earlier fiscal years, Income towards Parent Company was -$9.57 million in FY2025, -$12.85 million in FY2024, -$42.43 million in FY2023 and -$9.82 million in FY2022.
- Quarterly Income towards Parent Company has moved between -$29.09 million (fiscal Q4 2023) and $636,000 (fiscal Q4 2025) over five years.
- Per Business Quant data, GRCE's Income towards Parent Company in the three fiscal quarters before Q2 2027 was -$15.79 million (Q1 2027), -$1.18 million (Q4 2026) and -$2.32 million (Q3 2026).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn |
| 10 | Grace Therapeutics | 35.10 Mn | -35.61 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -2.13 Mn |
| Jun 30, 2026 | -15.79 Mn |
| Mar 31, 2026 | -1.18 Mn |
| Dec 31, 2025 | -2.32 Mn |
| Sep 30, 2025 | -938,000.00 |
| Jun 30, 2025 | -3.36 Mn |
| Mar 31, 2025 | 636,000.00 |
| Dec 31, 2024 | -4.16 Mn |
| Sep 30, 2024 | -3.43 Mn |
| Jun 30, 2024 | -2.62 Mn |
| Mar 31, 2024 | -3.17 Mn |
| Dec 31, 2023 | -2.39 Mn |
| Sep 30, 2023 | -3.27 Mn |
| Jun 30, 2023 | -4.02 Mn |
| Mar 31, 2023 | -29.09 Mn |
| Dec 31, 2022 | -3.89 Mn |
| Sep 30, 2022 | -4.93 Mn |
| Jun 30, 2022 | -4.52 Mn |
| Mar 31, 2022 | -3.90 Mn |
| Dec 31, 2021 | -3.78 Mn |
Grace Therapeutics Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=GRCE&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "GRCE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=GRCE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();